Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF EQUITY (DEFICIT)

v3.7.0.1
CONSOLIDATED STATEMENTS OF EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Mar. 31, 2015 6,657,046        
Beginning balance, value at Mar. 31, 2015 $ 6,657 $ 82,238,507 $ (81,629,714) $ 35,933 $ 651,383
Issuance of common stock for cash, shares 959,140        
Issuance of common stock for cash, value $ 958 5,605,797     5,606,755
Loss on debt extinguishment         0
Issuance of common stock under cashless warrant exercises, shares 5,292        
Issuance of common stock under cashless warrant exercises, value $ 5 (5)      
Issuance of common stock due to rounding up from reverse split, shares 915        
Issuance of common stock due to rounding up from reverse split, value $ 1 (1)      
Stock-based compensation expense   202,844     202,844
Net loss     (4,872,329) (86,287) (4,958,616)
Ending balance, shares at Mar. 31, 2016 7,622,393        
Ending balance, value at Mar. 31, 2016 $ 7,621 88,047,142 (86,502,043) (50,354) 1,502,366
Issuance of common stock for cash, shares 216,078        
Issuance of common stock for cash, value $ 216 954,889     955,105
Issuances of common stock and warrants under registered direct financing, shares 773,000        
Issuances of common stock and warrants under registered direct financing, value $ 773 1,803,477     1,804,250
Issuances of common stock under conversions of convertible notes and related accrued interest, shares 33,091        
Issuances of common stock under conversions of convertible notes and related accrued interest, value $ 33 144,686     144,719
Loss on debt extinguishment   558,198     558,198
Debt discount on convertible notes payable   783,868     783,868
Repurchase of restricted stock units, shares 149,864        
Repurchase of restricted stock units, value $ 150 (378,668)     (378,518)
Exercise of cashless warrants, shares 2,660        
Exercise of cashless warrants, value $ 3 (3)      
Stock-based compensation expense   2,186,309     2,186,309
Net loss     (7,276,113) (30,613) (7,306,726)
Ending balance, shares at Mar. 31, 2017 8,797,086        
Ending balance, value at Mar. 31, 2017 $ 8,796 $ 94,445,739 $ (93,778,156) $ (80,967) $ 595,412